Se habla espanol
Se habla espanol
Trusted in Central Florida for 17+ years. Safe, physician-supervised GLP-1 care with science-backed protocols.
Clinician-guided GLP-1 care using semaglutide, with labs, gradual dose titration, and follow-ups. Svelte has provided physician-supervised weight-loss programs in Central Florida for more than 17 years.
Semaglutide is a GLP-1 medication that helps regulate appetite and blood sugar. Our program pairs medication with nutrition coaching and structured follow-ups for safe, sustainable progress.
We review history, medications, BMI, and order labs to confirm candidacy.
Begin at a low weekly dose; receive after-care guidance and nutrition tips.
Increase by protocol while we monitor side effects and progress.
Regular check-ins for habits, protein/fiber goals, and plan adjustments.
Eligibility is determined after clinical evaluation and labs.
Appointments with trained clinicians who review labs, discuss risks, and personalize your semaglutide plan.
Svelte has delivered physician-supervised weight loss locally for more than 17 years—grounded in follow-up and realistic goals.
This information is educational and not a substitute for medical advice. Medication eligibility, dosing, and duration are determined after clinical evaluation. Side effects and results vary.
This information is educational and not a substitute for medical advice. Medication eligibility, dosing, and duration are determined after clinical evaluation. Side effects and results vary.
Certain branded formulations of semaglutide—such as Wegovy®—are FDA-approved for the treatment of obesity and chronic weight management. Our clinic may also offer compounded semaglutide formulations, prepared by licensed pharmacies, when appropriate and medically indicated.
Compounded medications are not individually reviewed or approved by the FDA, but they are made under the supervision of qualified pharmacists in accordance with state and federal compounding guidelines. Each patient’s treatment plan is developed and monitored by a licensed medical provider to ensure safety, efficacy, and proper dosing.
This information is provided for educational purposes and should not be interpreted as medical advice or an endorsement of any specific medication. Individual results and eligibility vary based on clinical evaluation and lab results.
These effects often improve by starting at a low weekly dose and increasing gradually for approximately 16 weeks. Some medications may remain in the stomach longer; dosing is personalized by your clinician.
Not appropriate for people with any of the following:
Your provider will review your history and labs and discuss alternatives if semaglutide is not a fit.
Many clients notice early changes in the first few weeks. Individual results vary.
Semaglutide is a peptide that must be injected once a week. The dose starts low and increases over 16 weeks to reach the maximum dose for weight loss. The food you eat will remain in the stomach a little longer making you feel full sooner and limiting overeating. Insulin secretion will be optimized to carry sugar to the cell and not store fat. Semaglutide also mimics a hormone that targets areas of the brain to reduce appetite.
Candidates for Semaglutide have a BMI over 30, or over 27 with at least one related condition such as high blood pressure, high cholesterol or diabetes (Type 2). Or patients can have a body fat % of 30+ for females or 25+ for males. Clients who have tried other forms of weight loss or appetite suppressants may be great candidates for Semaglutide.
**We source Semaglutide from a Pharmacy that strictly follows FDA regulations, as well as local and state guidelines and operates under strict QC measures.
In June of 2021, the FDA approved specific branded formulations that contain Semaglutide for the chronic treatment of obesity. Traditionally, formulations such as Wegovy and Ozempic containing Semaglutide have been prescribed to treat Type 2 diabetics.
Possible Side Effects:
These side effects are controlled by starting at a low dose and increasing gradually over 16 weeks. Other
medications may stay in your stomach longer and their affect could be
delayed.
Clients with Type 1 Diabetes, pregnant or nursing or have/had thyroid cancer are NOT candidates for Semaglutide.
New and Existing Orlando weight loss patients and Biote patients can make an appointment online:
**We source Semaglutide from a Pharmacy that strictly follows FDA regulations, as well as local and state guidelines and operates under strict QC measures.
Book an Appointment in Dr. Phillips. This location serves Windermere, MetroWest, South West Orlando. Close to I4 and Sandlake Road.
Our Address: 7009 Dr Phillips Blvd Suite 240 Orlando, FL 32819
Phone: (407) 804-5200
Book an Appointment in East Orlando. This location serves East Orlando, Waterford Lakes, Colonial, UCF area, Lake Nona, and is close to 408 and 417
Our Address: 10902 Dylan Loren Circle Orlando, FL 32825
Phone: (407) 804-5200
Book an Appointment in Lake Mary. This location serves Longwood, Lake Mary, Sanford, and North Orlando area. Close to I4 East towards Deltona, Daytona and 417.
Our Address: 580 Rinehart Rd #120, Lake Mary, FL 32746
Phone: (407) 804-5200